Allosct | List of Frontiers open access articles

Case Report

Published on 27 Mar 2025

Case Report: Decitabine and venetoclax sequentially followed by FLAG-Ida and venetoclax with immediate allogeneic stem cell transplantation in newly diagnosed acute myeloid leukemia with chromosome 3 inversion/MECOM rearrangement

in Hematologic Malignancies

Andrius Žučenka
Milvydė Tamutytė

Frontiers in Oncology

doi 10.3389/fonc.2025.1530852

4,773 views
1 citation

Original Research

Published on 15 Apr 2020

Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT – A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party

in Alloimmunity and Transplantation

Olaf Penack
Christophe Peczynski
Steffie van der Werf
Jürgen Finke
Arnold Ganser
Helene Schoemans
Jiri Pavlu
Riitta Niittyvuopio
Wilfried Schroyens
Leylagül Kaynar

Frontiers in Immunology

doi 10.3389/fimmu.2020.00586

6,435 views
21 citations

Review

Published on 06 Jan 2022

BMT for Myelodysplastic Syndrome: When and Where and How

in Hematologic Malignancies

Akriti G. Jain
Hany Elmariah

Frontiers in Oncology

doi 10.3389/fonc.2021.771614

14,907 views
15 citations

Original Research

Published on 11 Aug 2020

Reduced Calcium Signaling Is Associated With Severe Graft-Versus-Host Disease: Results From Preclinical Models and From a Prospective EBMT Study

in Alloimmunity and Transplantation

Katarina Riesner
Steffen Cordes
Christophe Peczynski
Martina Kalupa
Constanze Schwarz
Yu Shi
Sarah Mertlitz
Jörg Mengwasser
Steffie van der Werf
Zinaida Peric

Frontiers in Immunology

doi 10.3389/fimmu.2020.01983

3,614 views
2 citations

Case Report

Published on 26 Apr 2019

Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for TP53 Mutant pre-B-ALL in a Patient With X-Linked Agammaglobulinemia

in Primary Immunodeficiencies

Menno C. van Zelm
Marsus Pumar
Peter Shuttleworth
Pei M. Aui
Joanne M. Smart
Andrew Grigg
Julian J. Bosco

Frontiers in Immunology

doi 10.3389/fimmu.2019.00895

5,718 views
15 citations

Original Research

Published on 25 Sep 2023

Spatial proteomics identifies a spectrum of immune dysregulation in acquired bone marrow failure syndromes

in Inflammation

Rachel M. Koldej
Ashvind Prabahran
Chin Wee Tan
Mandy Ludford-Menting
Huw Morgan
Nicholas Holzwart
Melissa J. Davis
David S. Ritchie

Frontiers in Immunology

doi 10.3389/fimmu.2023.1213560

5,987 views
4 citations

Systematic Review

Published on 31 Jul 2024

Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years

in Hematologic Malignancies

Si Yu Lin
Ke Jie Lu
Xiao Na Zheng
Jian Hou
Ting Ting Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1341631

3,034 views
2 citations

Original Research

Published on 27 Feb 2018

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction

in Alloimmunity and Transplantation

Peter van Balen
Boris van der Zouwen
Alwine B. Kruisselbrink
Matthijs Eefting
Karoly Szuhai
Ekaterina S. Jordanova
J. H. F. Falkenburg
Inge Jedema

Frontiers in Immunology

doi 10.3389/fimmu.2018.00331

4,917 views
6 citations

Original Research

Published on 10 Sep 2020

Reconstituting NK Cells After Allogeneic Stem Cell Transplantation Show Impaired Response to the Fungal Pathogen Aspergillus fumigatus

in Microbial Immunology

Esther Weiss
Jan Schlegel
Ulrich Terpitz
Michael Weber
Jörg Linde
Anna-Lena Schmitt
Kerstin Hünniger
Lothar Marischen
Florian Gamon
Joachim Bauer

Frontiers in Immunology

doi 10.3389/fimmu.2020.02117

5,371 views
8 citations

Mini Review

Published on 14 Sep 2021

Mouse Models of Antigen Presentation in Hematopoietic Stem Cell Transplantation

in Alloimmunity and Transplantation

Motoko Koyama
Geoffrey R. Hill

Frontiers in Immunology

doi 10.3389/fimmu.2021.715893

8,206 views
12 citations

Original Research

Published on 10 May 2023

CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis

in Alloimmunity and Transplantation

Chris David Lauruschkat
Ihsan Muchsin
Alice Rein
Florian Erhard
Denise Grathwohl
Lars Dölken
Carolin Köchel
Christine Susanne Falk
Hermann Einsele
Sebastian Wurster

Frontiers in Immunology

doi 10.3389/fimmu.2023.1148841

5,359 views
15 citations

Original Research

Published on 15 May 2023

Monitoring of strength, inflammation and muscle function in allogenic stem-cell transplantation patients – a pilot study for novel biomarker and risk stratification determination

in Alloimmunity and Transplantation

Sebastian Viktor Waldemar Schulz
Daniel Alexander Bizjak
Elena Moebes
Lucas John
Verena Wais
Donald Bunjes
Elisa Sala
Jürgen Michael Steinacker
Johannes Kirsten

Frontiers in Immunology

doi 10.3389/fimmu.2023.1129687

5,269 views
2 citations

Original Research

Published on 11 Dec 2023

ECP versus ruxolitinib in steroid-refractory acute GVHD – a retrospective study by the EBMT transplant complications working party

in Alloimmunity and Transplantation

Olaf Penack
Christophe Peczynski
William Boreland
Jessica Lemaitre
Ksenia Afanasyeva
Brian Kornblit
Manuel Jurado
Carmen Martinez
Annalisa Natale
Jose Antonio Pérez-Simón

Frontiers in Immunology

doi 10.3389/fimmu.2023.1283034

4,579 views
4 citations

Original Research

Published on 20 Aug 2020

HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study

in Cancer Immunity and Immunotherapy

Peter van Balen
Inge Jedema
Marleen M. van Loenen
Renate de Boer
H. M. van Egmond
Renate S. Hagedoorn
Conny Hoogstaten
Sabrina A. J. Veld
Lois Hageman
P. A. G. van Liempt

Frontiers in Immunology

doi 10.3389/fimmu.2020.01804

8,141 views
35 citations

Original Research

Published on 01 Aug 2023

Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion

in Alloimmunity and Transplantation

Eva A. S. Koster
Edouard F. Bonneville
Peter A. von dem Borne
Peter van Balen
Erik W. A. Marijt
Jennifer M. L. Tjon
Tjeerd J. F. Snijders
Daniëlle van Lammeren
Hendrik Veelken
Hein Putter

Frontiers in Immunology

doi 10.3389/fimmu.2023.1208814

3,103 views

Original Research

Published on 13 Mar 2024

Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation

in Alloimmunity and Transplantation

Eva A. S. Koster
Peter A. von dem Borne
Peter van Balen
Erik W. A. Marijt
Jennifer M. L. Tjon
Tjeerd J. F. Snijders
Daniëlle van Lammeren
Hendrik Veelken
J. H. Frederik Falkenburg
Constantijn J. M. Halkes

Frontiers in Immunology

doi 10.3389/fimmu.2024.1335341

3,768 views
7 citations

Articles

Case Report: Decitabine and venetoclax sequentially followed by FLAG-Ida and venetoclax with immediate allogeneic stem cell transplantation in newly diagnosed acute myeloid leukemia with chromosome 3 inversion/MECOM rearrangement

Association of Serum Ferritin Levels Before Start of Conditioning With Mortality After alloSCT – A Prospective, Non-interventional Study of the EBMT Transplant Complications Working Party

BMT for Myelodysplastic Syndrome: When and Where and How

Reduced Calcium Signaling Is Associated With Severe Graft-Versus-Host Disease: Results From Preclinical Models and From a Prospective EBMT Study

Functional Antibody Responses Following Allogeneic Stem Cell Transplantation for TP53 Mutant pre-B-ALL in a Patient With X-Linked Agammaglobulinemia

Spatial proteomics identifies a spectrum of immune dysregulation in acquired bone marrow failure syndromes

Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years

Tissue Damage Caused by Myeloablative, but Not Non-Myeloablative, Conditioning before Allogeneic Stem Cell Transplantation Results in Dermal Macrophage Recruitment without Active T-Cell Interaction

Reconstituting NK Cells After Allogeneic Stem Cell Transplantation Show Impaired Response to the Fungal Pathogen Aspergillus fumigatus

Mouse Models of Antigen Presentation in Hematopoietic Stem Cell Transplantation

CD4+ T cells are the major predictor of HCMV control in allogeneic stem cell transplant recipients on letermovir prophylaxis

Monitoring of strength, inflammation and muscle function in allogenic stem-cell transplantation patients – a pilot study for novel biomarker and risk stratification determination

ECP versus ruxolitinib in steroid-refractory acute GVHD – a retrospective study by the EBMT transplant complications working party

HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study

Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion

Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation